Early Stage Researcher 8: Anna Wojdala

Anna's PhD project foresees development of an immunoassay for detection of candidate Alzheimer’s Disease (AD) biomarker(s) in cerebrospinal fluid (CSF) and blood. The techniques applied for the assay development include Enzyme-Linked Immunosorbent Assay (ELISA) for detection in CSF and Single molecule array technology (Simoa®) for detection in blood. The final stage of the project implies clinical validation of the developed assay in relevant patient samples from large independent cohorts.